Suscribirse

Thyrotoxic periodic paralysis associated with lactic metabolic acidosis: Case report of an African man and review of literature - 14/07/23

Doi : 10.1016/j.ando.2023.01.007 
Maurine Allard a, , Mathilde Barrallier a, Hugo Pisaroni a, Mathilde Fichet a, Margot De La Vergne De Cerval a, Robin Pflaum a, Audrey Poisson a, Christèle Derrien a, Fabrice Bonnet a, Patricia Vaduva a
a Department of Endocrinology, University Hospital of Rennes, Rennes, France 

Corresponding author. CHU de Rennes, service d’endocrinologie, 16, boulevard de Bulgarie, 35000 Rennes, France.CHU de Rennes, service d’endocrinologie16, boulevard de BulgarieRennes35000France

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Thyrotoxic periodic paralysis (TPP) is a rare and most often acquired subtype of hypokalemic periodic paralysis. The association of varying degrees of muscle weakness, hyperthyroidism and hypokalemia characterizes it. The treatment requires potassium supplementation, control of hyperthyroidism and prevention measures. It is a frequent disease in Asian men, but much rare in Caucasian or African populations. This is the first report of TPP associated with lactic metabolic acidosis in an African man.

Case presentation

A 23 year-old African man, native from Morocco, with recurrent episodes of tetraparesis for eleven months, and abdominal pain, was referred for evaluation. Biochemical investigations showed severe hypokalemia associated with hyperthyroidism and lactic metabolic acidosis. His EKG showed signs of hypokalemia such as sinus tachycardia and U waves. After potassium supplementation, neurological recuperation was quick and complete. Thyroid ultrasound identified a hypoechogenic and hypervascularized goiter, associated with high levels of thyroid antibodies, in favor of Grave's disease. With antithyroid drugs and life-style changes, the patient did not have any other attack.

Review of literature

In addition to the case report, this article presents an extended review of literature, from the first large study reporting the diagnosis and incidence of TPP in 1957 to nowadays. Are reported here the latest information concerning epidemiology, clinical manifestations, complementary examinations, management and genetic finding. The lactic acidosis observed initially is exceptional, never described in TPP. TPP is a diagnostic and therapeutic emergency, requiring careful potassium supplementation, in order to avoid the risk of the onset of rebound hyperkalemia, to be maintained until the etiological treatment is effective. Paraclinical assessment with emergency EKG and electromyogram are essential to assess the impact.

Discussion

It is essential in the face of any hypokalaemic periodic paralysis, including in non-Asian subjects, to search hyperthyroidism.

Conclusions

This report demonstrates the importance of thyroid testing in case of acute muscle weakness, even in non-Asian patients in order to diagnose TPP. This is a rare but possible etiology, to be distinguished from the familial form of hypokalemic periodic paralysis. It also questions on the impact of TPP on energetic metabolism, in particular on lactic metabolism.

El texto completo de este artículo está disponible en PDF.

Keywords : Thyrotoxic periodic paralysis, TPP, Hypokalemic periodic paralysis, Paralysis, Thyrotoxicosis, Lactic acidosis, HPP, Periodic paralysis

Abbreviations : CACNA1S, EKG, EMG, FHPP, HPP, KCNJ18, SCN4A, SNPs, T3, T4, TPP, TSH


Esquema


© 2023  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 84 - N° 4

P. 440-445 - août 2023 Regresar al número
Artículo precedente Artículo precedente
  • Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients
  • Victor Vermot-Desroches, Kim Thia-Soui-Tchong, Perrine Raymond, Andrea Filip, Jacques Orgiazzi, Emmanuel Jouanneau, Caroline Froment Tilikete, Françoise Borson-Chazot, Romain Manet, Juliette Abeillon Du Payrat
| Artículo siguiente Artículo siguiente
  • Dual-phase computed tomography for localization of parathyroid lesions in children and adolescents with primary hyperparathyroidism
  • Anima Sharma, Virendra Patil, Vijaya Sarathi, Nilendu Purandare, Priya Hira, Saba Memon, Swati S. Jadhav, Manjiri Karlekar, Anurag R. Lila, Tushar Bandgar

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.